Massive Delisting of Medical Consumables in Shaanxi: Medtronic, Johnson & Johnson, Lepu Among Affected Giants
Medtronic
Medical Device Manufacturer
Johnson & Johnson
Medical Device R&D and Manufacturer
Stryker
Medical Device R&D, Production, and Sales Company
Abbott
Provider of Health Diagnostic Products and Health Diagnostic Management Solutions
3M
International Comprehensive Product Manufacturer
Weigao
Blood Purification Product R&D and Manufacturer
Chunlizhengda
Orthopedic Medical Device R&D and Manufacturer
*Advertisement
On September 4, the Shaanxi Provincial Public Resources Trading Center released the "Announcement on the Proposed Cancellation of the Online Listing Qualification for Certain Medical Consumables Products," planning to revoke the online listings for a large number of medical consumables.
The document states,The center has recently organized and carried out the comparison of the listing prices of medical consumables on the national provincial platforms.Henan, Zhejiang, TianjinThe three provinces platform conducts price comparisons,Products that fail to report the lowest online listing price from other provinces as required will have their online listing eligibility revoked, and applications for online listing of these products will not be accepted for one year.
According to the public announcement information,The medical consumable products involved in this cancellation of online listing qualifications,Up to31,578 units. Among themIncluding fromMedtronic,Johnson & Johnson, Stryker, Abbott,Boston Scientific, Olympus, Jiemai, BIOTRONIK, Baxter, 3M, B. Braun, Lepu, Weigao, Chunlizhengda, Dabo, LifetechA large number of products from leading consumables giants.
IfOne company, LePu Medical, has 475 consumable products listed., involving multiple categories such as coronary thrombus aspiration catheters, arterial dilation balloons, vascular sheaths, pressure pumps, and coronary guiding catheters.
The announcement shows that the public comment period for the above 31,577 products is:September 4, 2023 to September 11, 2023。
In other words, once the public comment period ends on September 12,TheseConsumable products will be directly delisted and cannot be relisted within 1 year, making it difficult to enter public hospitals!
Scan the code to view the "List of Products Proposed for Delisting" ↓↓
No price cut, out!Official "Heavy Punch" in the Governance of Consumables Prices
In fact,On July 27, the Shaanxi Provincial Public Resources Trading Center issued the "Notice on Special Governance of Listed Prices for Pharmaceuticals and Medical Consumables," stating:
To regulate the prices of pharmaceuticals and medical consumables listed in the "Price Limit Directory" on the procurement platform of this province. Relevant production enterprises are required toFrom July 31, 2023 to August 14, 2023Enter the procurement subsystem to adjust the lowest price of related consumables nationwide.
And the Notice explicitly stated that after the conclusion of this special price governance, relevant departments will...The first working day of each month,Carry out the work of comparing the lowest price nationwide for online listing prices.For products that fail to link up with the lowest price nationwide within 1 month as required, once verified,Disqualification from online listing, and no application for online listing in Shaanxi Province within one year.
From this perspective,The delisting of 31,000 medical consumables this time is a large-scale implementation of the document.
Next,Comparison of the Lowest Price of Medical Consumables in ChinaWill also continue as a regularized task.Continued EffectivenessClear out a large number of medical device companies and products that evade price regulation and are unwilling to lower prices from the market!
The implementation of normalized and large-scale governance in Shaanxi Province, along with the repeated signals from the state, targets all online medical consumables.Strengthening Regulatory RequirementsInseparable.
On July 26, the Data Quality Governance Promotion Conference for the Procurement Subsystem of the National Medical Insurance Information Platform was held, emphasizing the data quality governance of the procurement subsystem.In the governance of drug and consumable pricesThe significant importance, and it is clearly stated that the application should be strengthened.
Previously, the National Healthcare Security Administration (NHSA) also successively proposed at the national healthcare security conference in January and the national pharmaceutical centralized procurement and price management symposium in February that it is necessary toComprehensively promote the price governance of medicines and consumables.
Not only in Shaanxi Province, but also across China, a wave of整治热潮 has swept through the procurement platforms for medical consumables in various provinces.
Including Yunnan, Hubei, Hebei, Sichuan, and Inner Mongoliaand many other provinces,All focus on the key governance of medical consumables listing prices, includingProduct price exceeds the price cap, and the lowest procurement price in China has not been reported.etc.If enterprises fail to adjust prices within the deadline or conceal the prices from other provinces, their products will be directly removed from the online procurement list.
At the same time, the hospital's admission review has become even stricter.Some regions have explicitly banned public hospitals from using non-listed consumables.
On May 9, the Health Bureau of Changle District, Fuzhou City released the "Announcement on the Status of Inspection and Rectification," addressing the issue of the unremarkable effectiveness in controlling unreasonable growth of medical expenses at Changle District Hospital in Fuzhou City, requiring the hospital...Pay attention to the listing status on the Sunshine Platform and promptly notify the clinical departments.Immediately notify the department to stop using upon discovery of the removal from the network.And executeConduct a hospital-wide self-inspection once every quarter, and each department conducts a self-inspection once a month., Strengthen the procurement management of high-value consumables and prohibit departments from using high-value consumables that are not listed on the official procurement platform.
In other words, under the combination of strict policy control and market suspension, once because ofDecomposing codes, repeating codes, and other violationsNon-compliance with online registration, failure to truthfully declare the lowest purchase price,Failure to meet the online price limit and other forms of evading price supervisionThe behavior of being removed from the network may come at the cost of losing the entire public hospital market in China...
Note:The above content is for reference only and does not constitute investment advice.The interpretation of official policies in this article only represents the views of this platform, and the content shall be subject to official documents. If other platforms reprint this article, they shall be responsible for it themselves. The Medical Device Dealers Alliance shall not be responsible for the impact caused by the secondary dissemination of the reprinted article.
IVD Practitioners Marketing Professional Course
*Advertisement
